课题基金 / 基金详情

Use of ondansetron in pregnancy and the risk of fetal abnormalities

Use of ondansetron in pregnancy and the risk of fetal abnormalities
怀孕期间使用昂丹司琼和胎儿畸形的风险
批准号:
353681
负责人:
Brard Anick
金额:
$7.29万
依托单位:
依托单位国家:
加拿大
项目类别:
Miscellaneous Programs
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-08-01 至 2017-08-01
关键词:

项目摘要

项目成果

Brard Anick的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The use of ondansetron in the context of nausea and vomiting during pregnancy is not indicated in Canada. The totality of the evidence reviewed regarding the potential for increased risk of fetal abnormalities with pregnancy exposure to ondansetron remain
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The CAnadian Mother-Child Initiative - knowledge mobilization from COnception to adulthood - CAMCCO-Outreach.
The CAnadian Mother-ChIld COLlaborative Training Platform - The CAMCCO-L Training Platform - SPOR Supplement
Canada Research Chair - Tier 1
  • 批准号:
    454003
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2021
  • 负责人:
    Brard Anick
  • 依托单位:
The CAnadian Mother-ChIld COLlaborative Training Platform - The CAMCCO-L Training Platform